Skip to main content

Table 4 Univariate and multivariate Cox regression analysis for predicting MACE

From: Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome

Variables

HR

Univariate

P value

HR

Multivariate

P value

95% CI

95% CI

TyG index

1.471

1.238–1.748

< 0.001

1.455

1.208–1.753

< 0.001

Age

1.041

1.024–1.058

< 0.001

1.039

1.022–1.057

< 0.001

Male

1.227

0.969–1.554

0.089

   

Duration of diabetes

1.012

0.997–1.026

0.117

   

Smoker

1.253

0.994–1.581

0.056

   

Hypertension

0.965

0.736–1.265

0.796

   

Previous MI

1.807

1.350–2.419

< 0.001

1.439

1.048–1.975

0.024

Previous PCI

1.221

0.928–1.607

0.154

   

Previous CABG

1.842

1.170–2.901

0.008

   

Previous stroke

0.991

0.745–1.319

0.951

   

BMI

1.045

1.005–1.086

0.027

   

AMI

1.939

1.514–2.484

< 0.001

   

LVEF

0.955

0.945–0.966

< 0.001

0.968

0.955–0.981

< 0.001

Left main disease

1.600

1.161–2.206

0.004

   

Multi-vessel disease

1.568

1.119–2.197

0.009

   

Revascularization

0.873

0.677–1.125

0.294

   

HbA1c

1.077

0.997–1.164

0.061

   

LDL-C

1.085

0.966–1.218

0.171

   

Uric acid

1.001

0.999–1.002

0.276

   

hs-CRP

1.009

1.005–1.012

< 0.001

1.004

1.000–1.008

0.031

NT-proBNP

1.001

0.999–1.003

0.331

   

eGFR

0.997

0.992–1.002

0.247

   

Statin

0.599

0.388–0.926

0.021

0.578

0.371–0.901

0.015

Insulin

1.210

0.960–1.526

0.107

   
  1. TyG index triglyceride-glucose index, MI myocardial infarction, PCI percutaneous coronary intervention, AMI acute myocardial infarction, LVEF left ventricle ejection fraction, HbA1c Hemoglobin A1c, LDL-C low-density lipoprotein cholesterol, hs-CRP high-sensitivity C-reactive protein, NT-proBNP N-terminal proB-type natriuretic peptide, eGFR estimated glomerular filtration rate, MACE major adverse cardiovascular event, HR hazard ratio, CI confidential interval